Advice You - Finance

As the credit card market becomes more competitive than ever, banks and lending institutions are coming up with new marketing and financial strateg

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ies to obtain more customers. One of those strategies used to acquire more customers is through the use of a cash back credit card.

By definition,

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

those are credit cards that will return a fixed percentage of cash back to the customer according to the amount of purchases charged on the credit

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ard. Usually, the cash back rebate is typically anywhere between 1 to 2% and is computed within a given time frame. Therefore, cash back credit c

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

rds might result in a good saving tool if used properly and conscientiously.

Let’s assume that a given person will use his/her credit card and wil

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

also carry a monthly card balance. If the ongoing interest rate is very high, the finance charges will or than likely offset any of the savings ga

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ined from the cash rebates. On the other hand, if the card balance is paid in full at the end of every grace period, the cash back rebates earned f

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

om the credit card will usually end up earning the cardholder money back and sometimes a significant amount depending on how often the card is used

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

Cash back credit cards will payout the cash rebates earned either by crediting the actual earned rebate back against the existing card balance or

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

will pay the cardholder with a rebate check, usually in $50 to $100 increments.

With the notion of accumulating cash with card purchases, people w

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ll psychologically tend to use their credit cards more than other payment options. Very often, cardholders will set a specific time frame for thei

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

r card purchase activities in order to accumulate the most cash rebates possible. As more and more companies accept credit cards, cardholders are b

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

coming more and more comfortable with using their respective cards to pay virtually everything including utility bills, mortgages and rent payments

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

With a 1% to as high as a 5% cash back bonus on all purchases, cardholders anticipate some hefty savings from a cash back credit card.

Not surpr

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

singly, cash back credit cards are very popular with consumers. But cardholders must be wary of using them correctly, if they wish to derive maximu

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

benefit. Banks and credit card issuers typically design the cards to maximize their own profit not the consumers profit because card issuers anti

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

cipate the cards will not be used efficiently by some, if not many of the cardholders utilizing these cards.

Cash back credit cards are among the

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

any financial tools that can be truly rewarding for cardholders that use the cards effectively and look beyond just the pure attraction of receivin

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

cash back. If cardholders are vigilante about paying off their card balances each and every month, they can potentially rack up significant saving

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

from a cash back credit card. But if not, they might end up paying out significantly more in finance charges over time than their old credit card

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/92027/adviceyou-Cash-Back-Credit-Card-How-Rewarding-Is-It.html">Cash Back Credit Card: How Rewarding Is It?</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/92027/adviceyou-Cash-Back-Credit-Card-How-Rewarding-Is-It.html]Cash Back Credit Card: How Rewarding Is It?[/url]

Charles Schwab became the most successful marketing executive this world ever had. Every business guru of that time agreed that two characteristics of Charles Schwab, his smile and his power of polite convincing, helped Andrew to make his billions. Smile is a great power and luckily it is free.

Getting a ranking in search engine queries for highly competitive categories is becoming more and more difficult. The most important factor in getting a high ranking is to build a site that truly deserves to get a top ranking; a site that provides much useful information about the subject that is being searched for. However, in addition to providing relevant content, it is the presentation of the content that plays an important part in separating sites that reach the top of search engine queries and those that are buried on page 25. One factor in presentation and optimization that is often underestimated is the naming of files and directories.

You can also purchase or hire lists from other people. This can be a risk since such lists are not targeted. However, you can dip your toe in the water by trying a fairly short list at first at minimum cost and sending them an email. This should include an offer for something relevant to your website, but nothing free. They possibly got onto the list through accepting a free offer in exchange for their email address, and they might do the same for you. However, such an address on your own list would not be worth having...

Tags

Links

Advice You - Cash Back Credit Card: How Rewarding Is It?

Related Articles: